Tag: WHO

  • Unhealthy situation

    Unhealthy situation

    A recent report quoted the UK’s Nursing and Midwifery Council (NMC) as saying, “As on 30 September 2025, there were 16,156 nurses on the register who were educated in Nigeria.” It is the regulatory body in the UK responsible for registering qualified professionals and investigating concerns related to nurses, midwives, and nursing associates. Notably, as of March 31, 2025, the number of Nigerian-trained nurses was 15,421. These figures show a nearly five percent rise over the six months.

    Indeed, the 2025 Nigeria Health Statistics Report, released by the Federal Ministry of Health and Social Welfare in November, corroborated the continued large-scale medical migration. The report revealed the sheer magnitude of brain drain in the country’s health sector, describing the situation as “a significant challenge.”

    According to the document, 43,221 health professionals—including doctors, nurses, pharmacists and medical laboratory scientists—migrated out of the country between 2023 and 2024, relocating to countries offering better remuneration and working conditions.

    “External migration surged by 200 percent across all cadres between 2023 and 2024,” the report said. It further revealed that “In 2024 alone, a total of 4,193 doctors and dentists left Nigeria, with approximately 66 percent migrating to the United Kingdom.”

    Read Also: Tinubu must complete eight years as president – Wike

     The report listed the top 10 destinations for Nigerian doctors and dentists in the 2023–2024 period: the United Kingdom (4,627), Canada (934), the United States (561), Australia (188), the United Arab Emirates (140), Ireland (113), the Maldives (77), Botswana (67), India (57) and Saudi Arabia (43).

    Nurses and midwives “are the most affected groups,” the report said, with more than 23,000 migrating abroad as of 2024. Pharmacists and medical laboratory scientists also joined the flight to foreign lands, deepening the loss. 

    Predictably, this exodus means fewer personnel are left to cope with the increasing demand for healthcare, posing a severe threat to the country’s system. Consequently, the report underlined the urgent need for policies aimed at retaining health workers and strengthening domestic capacity.

     It is noteworthy that the Minister of State for Health and Social Welfare, Dr Iziaq Salako, also acknowledged the workforce crisis during the Joint Annual Report meeting of the health sector in Abuja.

    He said: “Our doctor-to-population ratio is 1:5,000 (against the WHO recommendation of 1:600), while the nurse-to-population ratio is as low as 1:2,000 (against the WHO recommendation of 1:300).”

    There is no doubt that the escalating exodus of healthcare professionals from the country is detrimental to its health sector.  The situation calls for urgent intervention by the authorities; the nation cannot afford to continue losing its healthcare experts by failing to provide an enabling environment for their work.

  • Nigeria in global spotlight as WHO launches traditional medicine advisory group

    Nigeria in global spotlight as WHO launches traditional medicine advisory group

    The World Health Organisation’s decision to launch its first-ever Strategic and Technical Advisory Group on Traditional, Complementary and Integrative Medicine (STAG-TM) has resonated far beyond Geneva and New Delhi. For Nigeria, it marks a moment of validation—and opportunity—in a field long practised by millions but historically side-lined by global health governance.

    Announced last week, December 18, the new advisory group is central to implementing the WHO Global Traditional Medicine Strategy 2025–2034, an agenda designed to bring scientific rigour, policy coherence and regulatory clarity to a rapidly expanding sector of health care. Traditional medicine, WHO officials acknowledge, is no longer peripheral. It is embedded in cultural identity and increasingly forms the backbone of primary health care systems, particularly in Africa and other parts of the Global South. “This is a pivotal moment for traditional medicine,” said Dr Yukiko Nakatani, WHO Assistant Director-General for Health Systems, Access and Data. “It embodies cultural heritage and national health identities, and increasingly, it constitutes a vital component of primary health care strategies.”

    For Nigeria, the symbolism is especially strong. One of the two newly appointed co-chairs of the advisory group is Prof Martins Emeje, Director-General of the Nigeria Natural Medicine Development Agency (NNMDA). His appointment places Nigeria at the centre of global decision-making on how traditional medicine is researched, regulated and integrated into formal health systems. WHO Chief Scientist, Dr Sylvie Briand, explained that the rapid growth of traditional and complementary medicine has not been matched by strong evidence standards or sustainable governance. “The STAG was created to close this gap. It is not an academic exercise, but a formal WHO advisory mechanism providing independent, strategic and scientific guidance,” she said.

    The 19-member advisory group, selected through an open global process, will guide WHO on research priorities, technical standards, integration into national health systems and policy options for Member States. Its inaugural meeting, held in New Delhi on December 17 alongside the second WHO Global Traditional Medicine Summit, identified urgent priorities that mirror Nigeria’s long-standing challenges and ambitions: evidence generation, preservation of indigenous knowledge, digital innovation, regulation, and community engagement.

    For decades, Nigeria has grappled with how to harness its vast traditional medicine ecosystem—rich in biodiversity and indigenous knowledge—while addressing concerns around safety, efficacy and standardisation. The elevation of Prof Emeje, a long-time advocate of evidence-based natural medicine and pharmaceutical innovation, signals a shift from informal acceptance to structured global recognition. Beyond symbolism, Emeje said the implications are practical.

    Read Also: Mother who sold baby, drug dealer, others arrested in Delta

    Emeje said the significance of the WHO’s action lies in the global attention it places on Nigeria, noting that the world is watching, expecting, believing in, and trusting the country to provide leadership on the global discussion table in this critical area. He described the development as further evidence that the WHO is a highly inclusive institution, with demonstrable policies aimed at promoting the health and wellbeing of all people. According to him, the decision has also strengthened his personal resolve to continue serving Nigeria and the global community without expectation of reward. “This action by the WHO further fuels my passion to serve my country and the world selflessly,” he said.

    The NNMDA DG added that traditional medicine should not be framed as a competing or alternative system within Africa’s healthcare landscape. “Traditional medicine is not an alternative to any other form of medicine in Africa—at least for now,” he stated, stressing the need for complementarity, scientific validation and responsible integration into existing health systems.

    As WHO moves to draft the STAG-TM workplan for 2026–2027 and establish thematic sub-groups, Nigeria stands to influence global norms that could shape funding, research collaboration, intellectual property protection and the integration of traditional medicine into universal health coverage frameworks. In a country where millions still rely on herbal and traditional remedies as first-line care, the WHO’s move—and Nigeria’s prominent role within it—suggests that traditional medicine is no longer being asked to justify its existence. Instead, it is being challenged to meet global standards, while finally being given a seat at the table where those standards are set.

  • Nigeria scores global first as WHO names Emeje co-chair on traditional medicine governance

    Nigeria scores global first as WHO names Emeje co-chair on traditional medicine governance

    Nigeria has reached a significant global milestone in the governance of natural medicine, following the appointment of the Director General of the Nigeria Natural Medicine Development Agency (NNMDA), Professor Martins Emeje, as Co-Chair of the World Health Organisation’s (WHO) newly established Strategic and Technical Advisory Group on Traditional, Complementary and Integrative Medicine.

    The appointment places Emeje at the centre of the WHO’s efforts to strengthen health systems worldwide through evidence-based traditional and integrative medicine, under its Global Traditional Medicine Strategy 2025.

    Emeje was named Co-Chair alongside Dr Susan Wieland, Director at Cochrane Complementary Medicine, following the formal unveiling of the 19-member advisory group by the WHO. 

    The group is expected to provide high-level technical and strategic guidance on policy frameworks, research priorities, standards, and best practices for the safe and effective integration of traditional medicine into national health systems.

    Announcing the creation of the group, the WHO described it as “a decisive step in applying a scientific response to traditional medicine,” noting that the rapid global expansion of traditional and complementary medicine had outpaced the development of strong evidence, standards, and regulatory systems.

    At the inaugural meeting of the advisory group, held alongside the Second WHO Global Traditional Medicine Summit in New Delhi, India, the organisation’s Assistant Director General for Health Systems, Access and Data, Dr Yukiko Nakatani, said the moment marked a turning point for traditional medicine globally.

    “This is a pivotal moment for traditional medicine as it embodies cultural heritage, national health identities, and a vital component of policy healthcare strategies,” Nakatani said.

    She noted that the advisory group would help the WHO and its member states move from fragmented approaches to a more coordinated, science-driven framework that recognises both the cultural relevance and public health potential of traditional medicine.

    The WHO’s Chief Scientist, Dr Sylvie Briand, underscored the urgency of the initiative, warning that the sector’s rapid growth had not been matched by appropriate safeguards.

    “The situation whereby the rapid growth of traditional medicine has not been matched by strong evidence, standards, regulatory frameworks, or sustainable governance underscores the urgency of this initiative,” Briand said.

    Emeje’s appointment is widely seen as a recognition of Nigeria’s expanding role in research, innovation, and regulation of natural medicines. 

    As Director General of the Nigeria Natural Medicine Development Agency, he has led efforts to promote the scientific validation, regulation, and commercialisation of natural medicine products, while pushing for stronger quality assurance and evidence-based practice in the sector.

    His emergence as Co-Chair of the WHO advisory group signals growing confidence in Nigeria’s institutional capacity to contribute meaningfully to global health policy discussions, particularly in areas where traditional knowledge intersects with modern science.

    The Strategic and Technical Advisory Group on Traditional, Complementary, and Integrative Medicine is expected to advise the WHO on integrating traditional medicine into national health systems without compromising safety, efficacy, and quality. 

    Its work will include guidance on research methodologies, regulatory standards, innovation pathways, and governance models that align traditional practices with contemporary public health goals.

    According to the WHO, the establishment of the group is a core component of its Traditional Medicine Strategy 2025, which seeks to harness the benefits of traditional medicine while addressing long-standing concerns around unverified claims, inconsistent standards, and weak oversight.

    Observers say Emeje’s role as Co-Chair positions Nigeria to influence global conversations on how traditional medicine can be responsibly integrated into healthcare delivery, especially in low and middle-income countries where such practices remain a primary source of care for millions of people.

    The appointment also reinforces calls for African countries to move beyond informal use of traditional medicine towards structured systems backed by research, regulation, and innovation.

    With the advisory group now formally inaugurated, expectations are high that its work will help bridge the gap between cultural heritage and scientific validation, ensuring that traditional medicine contributes meaningfully to universal health coverage and sustainable health systems worldwide.

  • WHO flags deepening poverty as major barrier to healthcare access in Africa

    WHO flags deepening poverty as major barrier to healthcare access in Africa

    The World Health Organization (WHO) has raised fresh concern over the scale of financial hardship caused by healthcare costs across Africa, warning that millions are being pushed deeper into poverty because they cannot afford basic medical treatment.

    The latest global Universal Health Coverage (UHC) report shows that in 2022, more than 423 million people in Africa faced financial hardship due to out-of-pocket health spending, with over 384 million pushed into or further into poverty.

    Africa also accounts for over 20 percent of the world’s population experiencing financial distress from medical bills and nearly a quarter of global health-driven poverty.

    Out-of-pocket payments still dominate health financing across the continent. In 31 countries, they make up more than a quarter of total health expenditure; in 11 countries, more than half; and in two countries, more than 70 percent.

    According to the organization, these pressures force families into agonizing choices that undermine well-being and widen inequality.

    Marking Universal Health Coverage Day 2025, the WHO Regional Director for Africa, Dr Mohamed Janabi, in his message on Friday, said the figures reflect a crisis that demands urgent political action.

    “Today, as we mark Universal Health Coverage Day under the banner Unaffordable health costs? We’re sick of it; we are reminded that health is not a privilege for the few. It is a fundamental human right and should be accessible to all,” he said.

    He warned that for too many people, the cost of care determines whether they seek treatment, delay it, or avoid it completely, noting, “These are not statistics. They are the lived realities of households selling assets, postponing care, or slipping deeper into vulnerability.”

    He noted that financial barriers continue to pit essential care against basic survival needs, forcing impossible choices between care and food, between medicines and school fees, between dignity and survival.

    Despite these challenges, Janabi pointed to areas of progress, noting that between 2015 and 2022/23, the African Region recorded improvements across all components of the UHC Service Coverage Index, including maternal and child health, infectious and non-communicable diseases, and access to care.

    He added that Africa achieved the world’s strongest gains in NCD service coverage, largely due to a decline in tobacco use. “These advances show what is possible with sustained commitment,” he said.

    However, he cautioned that progress remains uneven and that financial protection is still the region’s most persistent barrier, stressing that women, children, older persons, and rural households continue to bear the highest burden of health costs.

    “High health costs continue to undermine efforts to reduce poverty, prevent disability, and increase survival,” he said.

    Calling for urgent reforms, Dr Janabi urged governments, partners, and civil society to accelerate efforts to make healthcare affordable for everyone.

    He said priorities should include increasing domestic investment in health, expanding universal prepayment and risk-pooling systems, strengthening primary healthcare, and investing in the health workforce, facilities, supply chains, and data systems to guarantee not just access to care but access to quality care.

    He also called for stronger accountability and the use of disaggregated data to ensure resources reach underserved communities.

    “With new regional and global evidence in hand, 2025 offers a pivotal opportunity to accelerate financial protection reforms and advance health for all,” he said, adding that the WHO African Region stands ready to support governments with policy guidance, technical expertise, and data-driven decision-making.

    Dr Janabi urged African countries to move from commitment to concrete implementation, adding, “Let’s turn commitment into action. Let’s build resilient, inclusive, and equitable health systems that shield people from financial hardship – systems that uphold dignity, expand opportunity, and ensure that every person can exercise their right to health, without financial barriers.”

    He said this year’s UHC Day reaffirms a collective continental pledge, “On UHC Day 2025, we renew our shared promise, ‘Health for All. No One Left Behind.”

  • WDoR: WHO, UN call for more action on road safety

    WDoR: WHO, UN call for more action on road safety

    As the world marks the World Day of Remembrance for road traffic victims, the World Health Organization and the United Nations have called on countries to prioritise and commit to reducing road deaths by 2030. 

    This was stated in different statements by the Director, Department of Health determinants, promotion and prevention, Dr Etienne Krug, and the United Nations Secretary-General Special Envoy for Road Safety, Jean Todt. 

    According to Krug, there is a need for the government to make road safety a political priority and ensure sustained funding and advance action to achieve the goal of halving road deaths by 2030.

    He stated that everyone has a role to play in prioritizing safety and calling for urgent action: “Road safety is a crisis that has gone on for far too long, and no road death can ever be acceptable.”

    The Director, who applauded the advocacies by families and survivors of road traffic crashes across the world, said that this has led to changed hearts, minds, and decisions, declaring that victims and their loved ones deserve nothing less than the best.

    “You inspire us by transforming trauma into action. Your stories bring more people to our cause, your advocacy changes hearts, minds, and decisions, and you are leaders in our world to build safe streets for people all over the world. Thank you for all you do to make our roads safer and avoid further tragedies.”

    Krug noted that the world is already at the midpoint of the decade of action for Road Safety 2021-2030, adding that if more efforts are put into policies and political will, the goal of halving road deaths by 2030 can still be achieved.

    In his statement, the United Nations Secretary-General’s Special Envoy for Road Safety, Jean Todt, said that the number of road deaths annually is equal to the population of Canada every year, stressing that this cannot be accepted as the world cannot continue to measure progress in premises where lives are being lost every hour.

    “In 2025, road crashes are still the number one killer for ages 5 – 29. These are children; how can we let it happen, and yet the lives lost and changed forever remain invisible? This is the cost of using the world’s roads, and it is unacceptable.”

    Todt lamented that, based on how things are going regarding road safety in countries, the goal to reduce road deaths by 50 per cent by 2030 may not be achieved, asking all hands to be on deck to make the goal to be.

    “We must respect laws, build safe infrastructure, and enforce safe road user behaviour as if the lives of our children depend on it because they do. Government must act, industries must innovate responsibly, and citizens must hold them to account. 

    “On this World Day of Remembrance, we mourn those we have lost, but mourning is not enough. The greatest tribute we can offer is to finally address this silent pandemic.

    On November 16 every year, the world comes together to remember those who lost their lives in road crashes. The global tagline for the day until 2030 is Remember, Support and Act while the 2025 theme is “Lost talents”.

    For each life lost or forever changed in a road crash, it takes away dreams, creativity, and potential, which are talents that the world will never see again.

    The World Day of Remembrance for Road Traffic Victims is commemorated in more than 100 countries around the globe. Activities include candlelight vigils, art exhibitions, community walks, and remembrance ceremonies.

    In Nigeria, the Federal Road Safety Corps (FRSC) collaborated with Kwapda’as Road Safety Demand (KRSD) to hold a symbolic walking and jogging exercise to mark the 2025 World Day of Remembrance for Road Traffic Victims and the International Road Crash Victims African Conference. 

    The event brought together stakeholders, advocates, survivors, and community members in a united call for safer roads and stronger preventive measures across the nation.

    The FRSC also held a solemn Juma’a prayer session at Labadidi Muslim community Juma’a mosque, where the Corps Marshal, Shehu Mohammed, represented by the Assistant Corps Marshal in charge of the Corps Transport Standardization Office, Hafiz Muhammed, reaffirmed its commitment to honouring victims, supporting survivors, and strengthening the national resolve to prevent avoidable tragedies on our roads.

  • WHO warns of rapid rise in global antibiotic resistance

    WHO warns of rapid rise in global antibiotic resistance

    Bacteria are rapidly developing resistance to antibiotics, the World Health Organisation (WHO) warned on Monday, with one in six laboratory-confirmed bacterial infections now caused by antibiotic-resistant pathogens.

    The organisation has quantified the problem for the first time in relation to 22 antibiotics that are commonly used to treat infections of the urinary tract, the gastrointestinal tract or the bloodstream, or sexually transmitted gonorrhoea.

    The WHO also looked at various combinations of bacteria and antibiotics, as the latest figures are from 2023.

    It found that resistance increased in more than 40 per cent of cases between 2018 and 2023, by five to 15 per cent per year, depending on the combination of bacteria and antibiotic.

    The study included 23 million data points from more than 100 countries.

    The WHO quoted Yvan Hutin, a Director at the global body as saying “antimicrobial resistance is widespread and threatening the future of modern medicine.

    “Antibiotic resistance causes many deaths. There are significant regional differences, with the problem particularly prevalent in countries with weak health systems.

    “In South-East Asia and Eastern Mediterranean, one in three reported infections is already resistant to the antibiotics studied.”

    According to WHO data, 7.7 million people worldwide died from bacterial infections in 2021, with 1.1 million of these deaths directly attributable to antibiotic resistance.

    The WHO is urgently calling for more research and development of new antibiotics.
    (dp/NAN) 

  • WHO raises alarm as e-cigarettes spark fresh nicotine crisis

    WHO raises alarm as e-cigarettes spark fresh nicotine crisis

    Despite two decades of global decline in tobacco use, the World Health Organisation (WHO) has raised the alarm over a fresh wave of nicotine addiction, this time driven by e-cigarettes and other emerging tobacco products targeting the youth. A new WHO global report reveals that while the number of tobacco users has dropped from 1.38 billion in 2000 to 1.2 billion in 2024, a significant 27 per cent reduction, one in every five adults worldwide remains addicted.

    Even more worrying, over 100 million people are now using e-cigarettes, including 15 million adolescents aged 13–15, who are, on average, nine times more likely to vape than adults. WHO Director-General Dr Tedros Adhanom Ghebreyesus described the situation as a “fightback” by the tobacco industry, which is deploying sleek marketing tactics and new nicotine products, from e-cigarettes to heated tobacco and nicotine pouches, to recruit the next generation of users. “Millions are quitting thanks to tobacco control efforts,” he said. “But the tobacco industry is fighting back with new products aggressively targeting young people. Governments must act faster and stronger in implementing proven tobacco control policies.”

    For the WHO Director of Health Determinants, Promotion and Prevention, Dr Etienne Krug, “E-cigarettes are fuelling a new wave of nicotine addiction. They are marketed as harm reduction but, in reality, are hooking kids on nicotine earlier and risk undermining decades of progress.” The report shows that women are leading the global quit revolution. Between 2010 and 2024, the number of female tobacco users fell sharply from 277 million to 206 million, reducing global prevalence among women from 11 per cent to 6.6per cent. Women met the global 30 per cent reduction target for 2025 five years early, in 2020.

    Men, however, lag behind. With nearly one billion still using tobacco, men account for over 80 per cent of global users. Their prevalence dropped from 41.4per cent in 2010 to 32.5per cent in 2024, but at a pace too slow to meet global targets before 2031. WHO’s analysis presents a mixed picture of global tobacco use. South-East Asia recorded the most progress, with male tobacco use nearly halved, from 70 per cent in 2000 to 37 per cent in 2024, accounting for over half of the global decline. The Americas followed with a 36 per cent relative reduction, bringing prevalence down to 14 per cent.

    In contrast, Africa recorded the lowest prevalence globally at 9.5 per cent, but population growth continues to push up the absolute number of users. Europe now stands out as the world’s highest-prevalence region, with 24.1 per cent of adults still using tobacco. European women also have the highest female tobacco use globally, at 17.4 per cent. The Eastern Mediterranean region reported a prevalence rate of 18 per cent, with some countries showing rising trends, while the Western Pacific region showed the slowest progress, 22.9 per cent of adults still use tobacco, with men in the region recording the world’s highest prevalence at 43.3 per cent.

    Read Also: LASU: Maths dept rewards outstanding students, others

    WHO is calling for urgent action from governments to step up the fight against tobacco and nicotine products. The global health organisation recommends countries adopt and enforce the MPOWER package, a set of proven tobacco control measures under the WHO Framework Convention on Tobacco Control (FCTC). Key actions include raising tobacco taxes, banning advertising and sponsorships, closing regulatory loopholes for emerging products like e-cigarettes, and expanding cessation services to help millions quit. “Nearly 20 per cent of adults still use tobacco and nicotine products. We cannot let up now,” warned Dr Jeremy Farrar, WHO Assistant Director-General for Health Promotion and Disease Prevention. “The world has made gains, but stronger, faster action is the only way to beat the tobacco epidemic.”

  • WHO urges Nigeria, African nations to raise health spending

    WHO urges Nigeria, African nations to raise health spending

    The World Health Organization (WHO) has advised governments to raise public health expenditure to at least 20 percent of total health spending while reducing out-of-pocket costs to shield households from financial hardship.

    Delivering a goodwill message at the four-day Health Financing Dialogue organized by the National Health Insurance Authority (NHIA) in Abuja on Thursday, WHO Regional Director for Africa, Prof. Mohammed Janabi, stressed that sustainable health financing is vital to building resilient health systems. He urged Nigeria and other African countries to scale up investment in public health.

    Janabi, however, praised the Federal Government’s recent reforms, noting initiatives such as the Basic Healthcare Provision Fund (BHCPF), the NHIA Act, and the expansion of State-level insurance schemes as significant strides toward strengthening Nigeria’s health sector.

    “This means strengthening pooling and prepayment mechanisms and ensuring that every decision is guided by evidence such as cost-effectiveness and equity analyses. We must use resources wisely to create a fair and equitable financing structure,” he said.

    Janabi urged policymakers to seize the momentum of the Abuja dialogue to create lasting solutions, noting, “Let this Dialogue be remembered as a turning point where commitments become sustained action. Together, we can build a financing system that is inclusive, equitable, and responsive.”

    commending Nigeria’s leadership in health financing reforms, describing recent policy initiatives as timely and essential for the well-being of its over 223 million citizens and for the future of the African continent.

    “Nigeria’s leadership in health financing reform is timely and commendable,. With over 223 million citizens, how the country finances health is vital for the well-being of its people and the future of the continent. 

    “We know healthier populations are more productive, more resilient to shocks, and better able to drive inclusive growth,” Janabi said.

    The WHO Regional Director said the introduction of equity and investment units as well as the Legislative Network for Universal Health Coverage (UHC), which engages parliamentarians to push health reforms, offers inspiration to other African nations. 

    “Nigeria’s progress is encouraging. These steps are in the right direction and show the kind of leadership Africa needs in its health financing journey,” he noted.

    He reaffirmed WHO’s commitment to supporting Nigeria on its path to universal health coverage, emphasizing that health investments are not only a moral imperative but also an economic strategy for growth and resilience.

    “WHO stands ready as a partner on this journey,” Janabi said.

    The African Union (AU) and the Global Fund also praised Nigeria’s leadership in health financing reforms, describing the country as a model for Africa at a time of shrinking aid and global health challenges.

    AU Commissioner for Health, Humanitarian Affairs, and Social Development, Amb. Amma Adomaa Twum-Amoah, commended Nigeria’s recent approval of $1.7 billion for the HOPE Projects to strengthen governance, expand primary health care, and improve service delivery nationwide.

    “Today, Nigeria becomes the first West African nation to host such a dialogue, a milestone that comes at a time of shifting global financing, climate pressures and growing humanitarian crises.

    “Amid today’s constraints, Nigeria has charted a bold path. As Prof. P.L.O. Lumumba says, ‘If Nigeria gets it right, Africa will get it right,” Twum-Amoah said.

    She urged stronger African-led health security and regulatory systems, stressing that “Domestic investment is not only a public good but a catalyst for peace, security, and sustainable development… the surest path to realising Agenda 2063 – The Africa We Want.”

    Read Also: FULL LIST: Nigerian players who moved to EPL this transfer window

    Maria Kirova, on behalf of the Global Fund, commended Nigeria’s efforts against HIV, tuberculosis, and malaria, highlighting its investments in health security and infrastructure. 

    She outlined initiatives including expanded health insurance, over 60 oxygen facilities, supply chain upgrades, surveillance improvements, and PHC revitalization.

    “This dialogue comes at a critical time, when international financing is shrinking, and sustaining these investments is paramount,” she noted.

    The Abuja dialogue, the first in West Africa, aims to revive commitments from the 2001 Abuja Declaration for African nations to allocate at least 15% of their budgets to health.

    The health financing dialogue brought together government leaders, parliamentarians, development partners, and health sector stakeholders to address the funding gaps undermining access to quality healthcare in Nigeria.

  • Medicine: Nigeria beats Egypt South Africa, Rwanda, Ghana, others to WHO ML3 validation 

    Medicine: Nigeria beats Egypt South Africa, Rwanda, Ghana, others to WHO ML3 validation 

    …intensifies ML4 target 

    Nigeria has become the first national regulatory authority in Africa to sustain the World Health Organization’s (WHO) Maturity Level 3 (ML3) status for the regulation of medicines and vaccines, it emerged on Tuesday.

    The milestone is a critical prerequisite for vaccine manufacturing, representing a major boost to public health confidence while strengthening the country’s global trade prospects for medical products approved by the National Agency for Food and Drug Administration and Control (NAFDAC).

    It also enhances the nation’s standing in the international pharmaceutical sector.

    Tanzania (2018), Ghana (2020), Egypt (2022), Rwanda (2024), Senegal (2024) and Zimbabwe (2024) have all attained MP3 but Nigeria became the first to sustain it. 

    The recognition of the country’s ML3, effective until June 30, 2025, comes after WHO officials conducted assessments in Abuja and Lagos between November 25 and 29, 2024, alongside five follow-up Institutional Development Plan meetings held between February and May 2025, NAFDAC Director General (DG), Prof. Mojisola Adeyeye said.

    Adeyeye said the agency, in collaboration with the Pharmacy Council of Nigeria (PCN), is now pursuing Maturity Level 4 status and WHO-Listed Authority recognition, a milestone that would ease global market access for Nigerian-approved products. 

    Speaking at a joint news conference with the PCN Registrar and Chief Executive Officer (CEO), Babashehu Ahmed, in Abuja, Adeyeye said the achievement followed a rigorous Maturity Level 3 re-benchmarking exercise, a mandatory audit to confirm that the regulatory agency is maintaining the required standards.

    Read Also: WHO reaffirms Nigeria’s Maturity Level 3 status in medicines, vaccines regulation

    According to her, the evaluation, conducted in collaboration with NAFDAC and PCN, reviewed the country’s progress in meeting over 260 sub-indicators and implementing more than 800 recommendations from the previous assessment. 

    “The successful closure of all critical recommendations reaffirms Nigeria’s stable and integrated regulatory system.

    “All critical recommendations from the 2022 benchmarking were addressed, Adeyeye noted, reaffirming that NAFDAC and PCN operate a stable, integrated system.

    “WHO evaluated nine regulatory functions, including Market Authorization, Market Control, laboratory testing, and regulatory inspection. 

    “Collaboration between NAFDAC and PCN proved essential for ensuring licensing, manufacturing oversight, and coordinated inspections,” she said.

    However, the DG emphasized that Nigeria is already focused on achieving the next stage of WHO validation, noting that progress is well underway, with 27 of the 57 Maturity Level 4 indicators already closed, ongoing retraining of pharmaceutical inspectors, and continuous alignment of regulatory practices with international standards.

    PCN Registrar, Babashehu Ahmed, reiterated that both agencies are already closing Maturity Level 4 indicators, retraining pharmaceutical inspectors nationwide, and aligning their processes with global best practices. 

    He added that the collaboration between the two regulators is further demonstrated by their joint leadership of the newly inaugurated Federal Task Force, established to combat substandard medicines and unsafe food.

    “This milestone will attract investment, create jobs, and advance Nigeria’s goal of universal health coverage.

    “These achievements will not only protect public health but also strengthen Nigeria’s reputation, attract investment, and create jobs,” Ahmed emphasized.

  • WHO reaffirms Nigeria’s Maturity Level 3 status in medicines, vaccines regulation

    WHO reaffirms Nigeria’s Maturity Level 3 status in medicines, vaccines regulation

    Nigeria has retained the World Health Organisation (WHO) Maturity Level 3 (ML3) status for the regulation of medicines and vaccines, reaffirming its position as a continental leader in pharmaceutical oversight.

    The milestone was announced on Tuesday during a virtual press conference jointly addressed by NAFDAC Director-General, Prof. Mojisola Christianah Adeyeye, and the Pharmacists Council of Nigeria (PCN) Director-General, Prof. Ibrahim Ahmed.

    NAFDAC said WHO officially confirmed the feat on June 30, 2025, following a rigorous re-benchmarking exercise and institutional follow-up meetings.

    The assessment, held in Abuja and Lagos between November 25 and 29, 2024, was followed by five Institutional Development Plan (IDP) meetings between February and May 2025 to track progress on critical recommendations.

    According to the agency, the closure of all such recommendations signalled that Nigeria now operates a stable, well-functioning, and integrated regulatory system for medicines and vaccines.

    “NAFDAC and PCN remain the first national regulatory authority in Africa to sustain WHO’s ML3 rating — a benchmark that enables countries to manufacture vaccines and trade approved products globally.

    Read Also: JUST IN: Passenger who assaulted Ibom Air crew member remanded in Kirikiri

    “With about 260 sub-indicators and more than 800 recommendations under ML3, the re-benchmarking audit confirmed that NAFDAC has maintained the stringent standards required for regulatory excellence.”

    The achievement also advances Nigeria towards Maturity Level 4 (ML4), which has 57 indicators — 27 already closed and 30 remaining — and is a key step towards becoming a WHO-Listed Authority (WLA).

    NAFDAC said the status boost strengthens public confidence in its approved medical products, supports universal health coverage, and enhances Nigeria’s image and economy while creating jobs.

    “This is great news for Nigeria’s public health, the economy, and our global standing,” Prof. Adeyeye said, pledging to sustain the standards that earned the WHO endorsement.